Furthermore, mutations in essential epigenetic factor genes are prevalent in approximately 68% of pediatric T-ALL cases, including mutations in EZH2, SUZ12, and WT1, among others. This evidence concerns the gene WT1 and acute lymphoblastic leukemia.